novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

SGLT2 inhibitors a new option to manage patients with heart failure

25 Novembro 2020

SGLT2 inhibitors a new option to manage patients with heart failure

10th CIC - The best case in imaging

26 Setembro 2020
0

Vascular protection. Coronary heart disease and peripheral artery disease. Two sides of the same coin

25 Novembro 2020
0

-->